Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial
Table 2
Distributions of early and late adverse outcomes of cranial ultrasound, EEG variables, blood biomarkers, term diagnoses, and death according to the burden of cerebral hypoxia within or below the 4th quartile.